Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients
- Status
- UNKNOWN
- Phase
- PHASE1
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or Metastatic
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE3
Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer
- Status
- UNKNOWN
- Phase
- NA
Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2